Carregant...
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis
INTRODUCTION: The European Medicines Agency has suspended the use of ulipristal acetate (UPA) in the treatment of uterine fibroids and is reassessing its association with a risk of liver injury. OBJECTIVES: Our objectives were to characterize the post-marketing reporting of drug-induced liver injury...
Guardat en:
| Publicat a: | Drug Saf |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7686198/ https://ncbi.nlm.nih.gov/pubmed/32748236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-020-00975-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|